Clinical Trial Update: RESIST-ADT (Androgen Deprivation Therapy) [NA]

View source ↗

Summary

The RESIST-ADT trial, sponsored by the Dana-Farber Cancer Institute, has completed. It investigates androgen deprivation therapy for Prostate cancer with a focu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer, Physical Function | NA | Status: COMPLETED